APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI-Assisted Drug Discovery Software

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global AI-Assisted Drug Discovery Software Industry Growth and Trends Forecast to 2032

5 June 2026102 pages

Choose your research edition.

Industry ResearchAI-Assisted Drug Discovery Software Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal AI-Assisted Drug Discovery Software Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal AI-Assisted Drug Discovery Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI-Assisted Drug Discovery Software Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal AI-Assisted Drug Discovery Software Market Analysis and Forecast 2026-2032256 pages · $4,950 USD

Market perspective

According to APO Research, the global AI-Assisted Drug Discovery Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for AI-Assisted Drug Discovery Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for AI-Assisted Drug Discovery Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI-Assisted Drug Discovery Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the AI-Assisted Drug Discovery Software market include AIDDISON, Atomwise Inc, BenevolentAI, BullFrog AI, Cyclica, Exscientia, Genesis Therapeutics Inc, Insilico Medicine and Recursion Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global AI-Assisted Drug Discovery Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The AI-Assisted Drug Discovery Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AI-Assisted Drug Discovery Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AI-Assisted Drug Discovery Software.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global AI-Assisted Drug Discovery Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

AI-Assisted Drug Discovery Software Market by Company

AIDDISON

Atomwise Inc

BenevolentAI

BullFrog AI

Cyclica

Exscientia

Genesis Therapeutics Inc

Insilico Medicine

Recursion Pharmaceuticals

Verge Genomics

AI-Assisted Drug Discovery Software Segment by Type

On Premise Software

Cloud-Based Software

AI-Assisted Drug Discovery Software Segment by Application

Biopharmaceuticals

Pharmaceuticals

Others

AI-Assisted Drug Discovery Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-Assisted Drug Discovery Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI-Assisted Drug Discovery Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-Assisted Drug Discovery Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of AI-Assisted Drug Discovery Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global AI-Assisted Drug Discovery Software Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global AI-Assisted Drug Discovery Software Market Size by Region (2021-2026) & (US$ Million) Table 3. Global AI-Assisted Drug Discovery Software Market Share by Region (2021-2026) Table 4. Global AI-Assisted Drug Discovery Software Market Size by Region (2027-2032) & (US$ Million) Table 5. Global AI-Assisted Drug Discovery Software Market Share by Region (2027-2032) Table 6. Global AI-Assisted Drug Discovery Software Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global AI-Assisted Drug Discovery Software Market Size by Type (2021-2026) & (US$ Million) Table 8. Global AI-Assisted Drug Discovery Software Market Size Share by Type (2021-2026) Table 9. Global AI-Assisted Drug Discovery Software Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global AI-Assisted Drug Discovery Software Market Size Share Forecasted by Type (2027-2032) Table 11. North America AI-Assisted Drug Discovery Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America AI-Assisted Drug Discovery Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe AI-Assisted Drug Discovery Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe AI-Assisted Drug Discovery Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific AI-Assisted Drug Discovery Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific AI-Assisted Drug Discovery Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America AI-Assisted Drug Discovery Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America AI-Assisted Drug Discovery Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa AI-Assisted Drug Discovery Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa AI-Assisted Drug Discovery Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global AI-Assisted Drug Discovery Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global AI-Assisted Drug Discovery Software Market Size by Application (2021-2026) & (US$ Million) Table 23. Global AI-Assisted Drug Discovery Software Market Size Share by Application (2021-2026) Table 24. Global AI-Assisted Drug Discovery Software Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global AI-Assisted Drug Discovery Software Market Size Share Forecasted by Application (2027-2032) Table 26. North America AI-Assisted Drug Discovery Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America AI-Assisted Drug Discovery Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe AI-Assisted Drug Discovery Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe AI-Assisted Drug Discovery Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific AI-Assisted Drug Discovery Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific AI-Assisted Drug Discovery Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America AI-Assisted Drug Discovery Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America AI-Assisted Drug Discovery Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa AI-Assisted Drug Discovery Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa AI-Assisted Drug Discovery Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. AI-Assisted Drug Discovery Software Industry Trends Table 37. AI-Assisted Drug Discovery Software Industry Drivers Table 38. AI-Assisted Drug Discovery Software Industry Opportunities and Challenges Table 39. AI-Assisted Drug Discovery Software Industry Restraints Table 40. Global AI-Assisted Drug Discovery Software Revenue by Company (US$ Million) & (2021-2026) Table 41. Global AI-Assisted Drug Discovery Software Revenue Market Share by Company (2021-2026) Table 42. Global AI-Assisted Drug Discovery Software Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global AI-Assisted Drug Discovery Software Key Company Headquarters & Area Served Table 44. Global AI-Assisted Drug Discovery Software Company, Product Type & Application Table 45. Global AI-Assisted Drug Discovery Software Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global AI-Assisted Drug Discovery Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. AIDDISON Company Information Table 49. AIDDISON Business Overview Table 50. AIDDISON AI-Assisted Drug Discovery Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. AIDDISON AI-Assisted Drug Discovery Software Product Portfolio Table 52. AIDDISON Recent Development Table 53. Atomwise Inc Company Information Table 54. Atomwise Inc Business Overview Table 55. Atomwise Inc AI-Assisted Drug Discovery Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Atomwise Inc AI-Assisted Drug Discovery Software Product Portfolio Table 57. Atomwise Inc Recent Development Table 58. BenevolentAI Company Information Table 59. BenevolentAI Business Overview Table 60. BenevolentAI AI-Assisted Drug Discovery Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. BenevolentAI AI-Assisted Drug Discovery Software Product Portfolio Table 62. BenevolentAI Recent Development Table 63. BullFrog AI Company Information Table 64. BullFrog AI Business Overview Table 65. BullFrog AI AI-Assisted Drug Discovery Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. BullFrog AI AI-Assisted Drug Discovery Software Product Portfolio Table 67. BullFrog AI Recent Development Table 68. Cyclica Company Information Table 69. Cyclica Business Overview Table 70. Cyclica AI-Assisted Drug Discovery Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Cyclica AI-Assisted Drug Discovery Software Product Portfolio Table 72. Cyclica Recent Development Table 73. Exscientia Company Information Table 74. Exscientia Business Overview Table 75. Exscientia AI-Assisted Drug Discovery Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Exscientia AI-Assisted Drug Discovery Software Product Portfolio Table 77. Exscientia Recent Development Table 78. Genesis Therapeutics Inc Company Information Table 79. Genesis Therapeutics Inc Business Overview Table 80. Genesis Therapeutics Inc AI-Assisted Drug Discovery Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Genesis Therapeutics Inc AI-Assisted Drug Discovery Software Product Portfolio Table 82. Genesis Therapeutics Inc Recent Development Table 83. Insilico Medicine Company Information Table 84. Insilico Medicine Business Overview Table 85. Insilico Medicine AI-Assisted Drug Discovery Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Insilico Medicine AI-Assisted Drug Discovery Software Product Portfolio Table 87. Insilico Medicine Recent Development Table 88. Recursion Pharmaceuticals Company Information Table 89. Recursion Pharmaceuticals Business Overview Table 90. Recursion Pharmaceuticals AI-Assisted Drug Discovery Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Recursion Pharmaceuticals AI-Assisted Drug Discovery Software Product Portfolio Table 92. Recursion Pharmaceuticals Recent Development Table 93. Verge Genomics Company Information Table 94. Verge Genomics Business Overview Table 95. Verge Genomics AI-Assisted Drug Discovery Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Verge Genomics AI-Assisted Drug Discovery Software Product Portfolio Table 97. Verge Genomics Recent Development Table 98. North America AI-Assisted Drug Discovery Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America AI-Assisted Drug Discovery Software Market Size by Country (2021-2026) & (US$ Million) Table 100. North America AI-Assisted Drug Discovery Software Market Share by Country (2021-2026) Table 101. North America AI-Assisted Drug Discovery Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America AI-Assisted Drug Discovery Software Market Share Forecast by Country (2027-2032) Table 103. Europe AI-Assisted Drug Discovery Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe AI-Assisted Drug Discovery Software Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe AI-Assisted Drug Discovery Software Market Share by Country (2021-2026) Table 106. Europe AI-Assisted Drug Discovery Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe AI-Assisted Drug Discovery Software Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific AI-Assisted Drug Discovery Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific AI-Assisted Drug Discovery Software Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific AI-Assisted Drug Discovery Software Market Share by Country (2021-2026) Table 111. Asia-Pacific AI-Assisted Drug Discovery Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific AI-Assisted Drug Discovery Software Market Share Forecast by Country (2027-2032) Table 113. Latin America AI-Assisted Drug Discovery Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Latin America AI-Assisted Drug Discovery Software Market Size by Country (2021-2026) & (US$ Million) Table 115. Latin America AI-Assisted Drug Discovery Software Market Share by Country (2021-2026) Table 116. Latin America AI-Assisted Drug Discovery Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Latin America AI-Assisted Drug Discovery Software Market Share Forecast by Country (2027-2032) Table 118. Middle East & Africa AI-Assisted Drug Discovery Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Middle East & Africa AI-Assisted Drug Discovery Software Market Size by Country (2021-2026) & (US$ Million) Table 120. Middle East & Africa AI-Assisted Drug Discovery Software Market Share by Country (2021-2026) Table 121. Middle East & Africa AI-Assisted Drug Discovery Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Middle East & Africa AI-Assisted Drug Discovery Software Market Share Forecast by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. AI-Assisted Drug Discovery Software Product Image Figure 3. Global AI-Assisted Drug Discovery Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 5. Global AI-Assisted Drug Discovery Software Market Share by Region: 2025 VS 2032 Figure 6. Global AI-Assisted Drug Discovery Software Market Share by Region (2021-2032) Figure 7. North America AI-Assisted Drug Discovery Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe AI-Assisted Drug Discovery Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific AI-Assisted Drug Discovery Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America AI-Assisted Drug Discovery Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa AI-Assisted Drug Discovery Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. On Premise Software Image Figure 13. Global On Premise Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Cloud-Based Software Image Figure 15. Global Cloud-Based Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global AI-Assisted Drug Discovery Software Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global AI-Assisted Drug Discovery Software Market Share by Type 2025 VS 2032 Figure 18. North America AI-Assisted Drug Discovery Software Market Size Share by Type (2021-2032) Figure 19. Europe AI-Assisted Drug Discovery Software Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific AI-Assisted Drug Discovery Software Market Size Share by Type (2021-2032) Figure 21. Latin America AI-Assisted Drug Discovery Software Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa AI-Assisted Drug Discovery Software Market Size Share by Type (2021-2032) Figure 23. Biopharmaceuticals Image Figure 24. Global Biopharmaceuticals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Pharmaceuticals Image Figure 26. Global Pharmaceuticals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Others Image Figure 28. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global AI-Assisted Drug Discovery Software Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global AI-Assisted Drug Discovery Software Market Share by Application 2025 VS 2032 Figure 31. North America AI-Assisted Drug Discovery Software Market Size Share by Application (2021-2032) Figure 32. Europe AI-Assisted Drug Discovery Software Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific AI-Assisted Drug Discovery Software Market Size Share by Application (2021-2032) Figure 34. Latin America AI-Assisted Drug Discovery Software Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa AI-Assisted Drug Discovery Software Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 AI-Assisted Drug Discovery Software Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America AI-Assisted Drug Discovery Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America AI-Assisted Drug Discovery Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America AI-Assisted Drug Discovery Software Market Share by Country (2021-2032) Figure 41. Europe AI-Assisted Drug Discovery Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe AI-Assisted Drug Discovery Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe AI-Assisted Drug Discovery Software Market Share by Country (2021-2032) Figure 44. Asia-Pacific AI-Assisted Drug Discovery Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific AI-Assisted Drug Discovery Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific AI-Assisted Drug Discovery Software Market Share by Country (2021-2032) Figure 47. Latin America AI-Assisted Drug Discovery Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America AI-Assisted Drug Discovery Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America AI-Assisted Drug Discovery Software Market Share by Country (2021-2032) Figure 50. Middle East & Africa AI-Assisted Drug Discovery Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa AI-Assisted Drug Discovery Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa AI-Assisted Drug Discovery Software Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • On Premise Software
  • Cloud-Based Software
Applications
  • Biopharmaceuticals
  • Pharmaceuticals
  • Others
Companies covered
  • AIDDISON
  • Atomwise Inc
  • BenevolentAI
  • BullFrog AI
  • Cyclica
  • Exscientia
  • Genesis Therapeutics Inc
  • Insilico Medicine
  • Recursion Pharmaceuticals
  • Verge Genomics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global AI-Assisted Drug Discovery Software Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global AI-Assisted Drug Discovery Software Market Size by Region (2021-2032)
  5. 1.4.1 Global AI-Assisted Drug Discovery Software Market Size by Region (2021-2026)
  6. 1.4.2 Global AI-Assisted Drug Discovery Software Market Size by Region (2027-2032)
  7. 1.5 Key Regions AI-Assisted Drug Discovery Software Market Size (2021-2032)
  8. 1.5.1 North America AI-Assisted Drug Discovery Software Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe AI-Assisted Drug Discovery Software Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific AI-Assisted Drug Discovery Software Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America AI-Assisted Drug Discovery Software Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa AI-Assisted Drug Discovery Software Market Size Growth Rate (2021-2032)
2 AI-Assisted Drug Discovery Software Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 On Premise Software
  3. 2.1.2 Cloud-Based Software
  4. 2.2 Global AI-Assisted Drug Discovery Software Market Size by Type
  5. 2.2.1 Global AI-Assisted Drug Discovery Software Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global AI-Assisted Drug Discovery Software Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global AI-Assisted Drug Discovery Software Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global AI-Assisted Drug Discovery Software Market Size by Regions
  9. 2.3.1 North America AI-Assisted Drug Discovery Software Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe AI-Assisted Drug Discovery Software Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific AI-Assisted Drug Discovery Software Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America AI-Assisted Drug Discovery Software Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa AI-Assisted Drug Discovery Software Market Size Breakdown by Type (2021-2026)
3 AI-Assisted Drug Discovery Software Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Biopharmaceuticals
  3. 3.1.2 Pharmaceuticals
  4. 3.1.3 Others
  5. 3.2 Global AI-Assisted Drug Discovery Software Market Size by Application
  6. 3.2.1 Global AI-Assisted Drug Discovery Software Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global AI-Assisted Drug Discovery Software Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global AI-Assisted Drug Discovery Software Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global AI-Assisted Drug Discovery Software Market Size by Regions
  10. 3.3.1 North America AI-Assisted Drug Discovery Software Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe AI-Assisted Drug Discovery Software Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific AI-Assisted Drug Discovery Software Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America AI-Assisted Drug Discovery Software Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa AI-Assisted Drug Discovery Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 AI-Assisted Drug Discovery Software Industry Trends
  2. 4.2 AI-Assisted Drug Discovery Software Industry Drivers
  3. 4.3 AI-Assisted Drug Discovery Software Industry Opportunities and Challenges
  4. 4.4 AI-Assisted Drug Discovery Software Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by AI-Assisted Drug Discovery Software Revenue (2021-2026)
  2. 5.2 Global AI-Assisted Drug Discovery Software Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global AI-Assisted Drug Discovery Software Key Company Headquarters & Area Served
  4. 5.4 Global AI-Assisted Drug Discovery Software Company, Product Type & Application
  5. 5.5 Global AI-Assisted Drug Discovery Software Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global AI-Assisted Drug Discovery Software Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 AI-Assisted Drug Discovery Software Players Market Share by Revenue in 2025
  9. 5.6.3 2025 AI-Assisted Drug Discovery Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 AIDDISON
  2. 6.1.1 AIDDISON Company Information
  3. 6.1.2 AIDDISON Business Overview
  4. 6.1.3 AIDDISON AI-Assisted Drug Discovery Software Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 AIDDISON AI-Assisted Drug Discovery Software Product Portfolio
  6. 6.1.5 AIDDISON Recent Developments
  7. 6.2 Atomwise Inc
  8. 6.2.1 Atomwise Inc Company Information
  9. 6.2.2 Atomwise Inc Business Overview
  10. 6.2.3 Atomwise Inc AI-Assisted Drug Discovery Software Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Atomwise Inc AI-Assisted Drug Discovery Software Product Portfolio
  12. 6.2.5 Atomwise Inc Recent Developments
  13. 6.3 BenevolentAI
  14. 6.3.1 BenevolentAI Company Information
  15. 6.3.2 BenevolentAI Business Overview
  16. 6.3.3 BenevolentAI AI-Assisted Drug Discovery Software Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 BenevolentAI AI-Assisted Drug Discovery Software Product Portfolio
  18. 6.3.5 BenevolentAI Recent Developments
  19. 6.4 BullFrog AI
  20. 6.4.1 BullFrog AI Company Information
  21. 6.4.2 BullFrog AI Business Overview
  22. 6.4.3 BullFrog AI AI-Assisted Drug Discovery Software Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 BullFrog AI AI-Assisted Drug Discovery Software Product Portfolio
  24. 6.4.5 BullFrog AI Recent Developments
  25. 6.5 Cyclica
  26. 6.5.1 Cyclica Company Information
  27. 6.5.2 Cyclica Business Overview
  28. 6.5.3 Cyclica AI-Assisted Drug Discovery Software Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Cyclica AI-Assisted Drug Discovery Software Product Portfolio
  30. 6.5.5 Cyclica Recent Developments
  31. 6.6 Exscientia
  32. 6.6.1 Exscientia Company Information
  33. 6.6.2 Exscientia Business Overview
  34. 6.6.3 Exscientia AI-Assisted Drug Discovery Software Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Exscientia AI-Assisted Drug Discovery Software Product Portfolio
  36. 6.6.5 Exscientia Recent Developments
  37. 6.7 Genesis Therapeutics Inc
  38. 6.7.1 Genesis Therapeutics Inc Company Information
  39. 6.7.2 Genesis Therapeutics Inc Business Overview
  40. 6.7.3 Genesis Therapeutics Inc AI-Assisted Drug Discovery Software Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Genesis Therapeutics Inc AI-Assisted Drug Discovery Software Product Portfolio
  42. 6.7.5 Genesis Therapeutics Inc Recent Developments
  43. 6.8 Insilico Medicine
  44. 6.8.1 Insilico Medicine Company Information
  45. 6.8.2 Insilico Medicine Business Overview
  46. 6.8.3 Insilico Medicine AI-Assisted Drug Discovery Software Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Insilico Medicine AI-Assisted Drug Discovery Software Product Portfolio
  48. 6.8.5 Insilico Medicine Recent Developments
  49. 6.9 Recursion Pharmaceuticals
  50. 6.9.1 Recursion Pharmaceuticals Company Information
  51. 6.9.2 Recursion Pharmaceuticals Business Overview
  52. 6.9.3 Recursion Pharmaceuticals AI-Assisted Drug Discovery Software Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Recursion Pharmaceuticals AI-Assisted Drug Discovery Software Product Portfolio
  54. 6.9.5 Recursion Pharmaceuticals Recent Developments
  55. 6.10 Verge Genomics
  56. 6.10.1 Verge Genomics Company Information
  57. 6.10.2 Verge Genomics Business Overview
  58. 6.10.3 Verge Genomics AI-Assisted Drug Discovery Software Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Verge Genomics AI-Assisted Drug Discovery Software Product Portfolio
  60. 6.10.5 Verge Genomics Recent Developments
7 North America
  1. 7.1 North America AI-Assisted Drug Discovery Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America AI-Assisted Drug Discovery Software Market Size by Country (2021-2026)
  3. 7.3 North America AI-Assisted Drug Discovery Software Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe AI-Assisted Drug Discovery Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe AI-Assisted Drug Discovery Software Market Size by Country (2021-2026)
  3. 8.3 Europe AI-Assisted Drug Discovery Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific AI-Assisted Drug Discovery Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific AI-Assisted Drug Discovery Software Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific AI-Assisted Drug Discovery Software Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America AI-Assisted Drug Discovery Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America AI-Assisted Drug Discovery Software Market Size by Country (2021-2026)
  3. 10.3 South America AI-Assisted Drug Discovery Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa AI-Assisted Drug Discovery Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa AI-Assisted Drug Discovery Software Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa AI-Assisted Drug Discovery Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst